Search

everythinglearnresearchcommunity

for

Search:↓

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

The β-sitosterol hair gel is effective and promising for treating hair loss.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Betula platyphylla extract, particularly the H3-2 fraction, may help treat hair loss by promoting cell growth and inhibiting a hair loss-related enzyme.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Annurca apple extract improved hair growth in mice and could potentially prevent hair loss.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Exosomes may help stimulate hair growth and improve hair loss conditions like androgenic alopecia.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.